
Neil Adrian Zakai MD
Assistant Professor, Medicine, University of Vermont College of Medicine
Join to View Full Profile
S Prospect St# 89Burlington, VT 05405
Phone+1 802-847-5971
Fax+1 802-847-5946
Dr. Zakai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Roger Williams Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of Vermont Medical CenterResidency, Internal Medicine, 2000 - 2003
- University of Virginia School of MedicineClass of 2000
Certifications & Licensure
- NY State Medical License 2021 - 2026
- VT State Medical License 2003 - 2026
- RI State Medical License 2005 - 2007
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Utilization Patterns and Outcomes From Iron Chelation Therapy in Elderly Patients With Myelodysplastic Syndromes: A Population Analysis.Aneta Strumilowska, Andrew Sparks, Neil Zakai, Diego Adrianzen Herrera
Clinical Lymphoma, Myeloma & Leukemia. 2025-09-01 - Association between serum adiponectin and risk of incident hypertension: the REGARDS study.Aneesh M Singal, Virginia J Howard, Suzanne E Judd, April P Carson, Neil A Zakai
Journal of Hypertension. 2025-08-01 - Risk factors for venous thrombosis after discharge from medical hospitalizations: the Medical Inpatient Thrombosis and Hemostasis study.Ryan M Thomas, Andrew D Sparks, Katherine Wilkinson, Mansour Gergi, Allen B Repp
Journal of Thrombosis and Haemostasis. 2025-07-01
Journal Articles
- All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous ThromboembolismNeil A Zakai, Terrence J Adam, Thrombosis and Haemostasis
- Mechanisms and Mitigating Factors for Venous Thromboembolism in Chronic Kidney Disease: The REGARDS StudyM Cushman, N A Zakai, G Howard, Journal of Thrombosis and Haemostasis
- Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS)Monika M Safford, Mary Cushman, Brett Kissela, Neil A Zakai, Thrombosis and Haemostasis
Abstracts/Posters
- Post Discharge Risk of Venous Thromboembolism in a Primary Care PopulationNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Assessing Venous Thromboembolism Risk in Critically Ill Children: A Report from the ChildrenÍs Hospital-Acquired Thrombosis (CHAT) ConsortiumNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The ChildrenÍs Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine LearningNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE PatientsSeptember 1st, 2025
- HI-PRO: Apixaban Lowers Risk of VTE in Patients with Transient Provoking FactorsAugust 30th, 2025
- Diagnosis and Follow‐up of Thrombotic Thrombocytopenic Purpura with an Automated Chemiluminescent ADAMTS13 Activity ImmunoassayDecember 15th, 2020
- Join now to see all
Grant Support
- Thrombosis and Bleeding Risk Assessment in Medical InpatientsUNIVERSITY OF VERMONT & ST AGRIC COLLEGE2019–2025
Professional Memberships
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: